{"disease":{"id":"uncontrolled-type-2-diabetes-mellitus","name":"uncontrolled type 2 diabetes mellitus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04801199","title":"Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":355,"lead_sponsor_name":"Cadila Pharnmaceuticals","has_results":false},{"nct_id":"NCT03125694","title":"Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Tehran University of Medical Sciences","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}